Commission on Cancer Quality Measures
The Maury Regional Cancer Center is accredited by the Commission on Cancer (CoC). As an accredited program, the organization collects and reports CoC standardized quality of care measures. The most common cancer diagnoses for our region in order of incidence rate are lung, breast, prostate, colorectal and bladder cancers.
View the full Cancer Report (PDF)
Incidence
Site-Specific Data
The data below includes the CoC quality of care measures by cancer site for 2016, the most recent year for which data is available. At this time, CoC standardized quality of care measures for prostate cancer have not been defined and bladder measures are in the surveillance phase with no comparative data. As a result, prostate and bladder cancer is not addressed in this report.
Breast
HORMONE THERAPY (HT)
Tamoxifen or third generation aromatase inhibitor is recommended or administered within 1 year (365 days) of diagnosis for women with AJCC T1c or stage IB-III hormone receptor positive breast cancer (Accountability).
MASTECTOMY WITH RADIATION THERAPY (MASTRT)
Radiation therapy is recommended or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with 4 positive regional lymph nodes (Accountability).
BREAST CONSERVATION SURGERY WITH RADIATION THERAPY (BCSRT)
Radiation is administered within 1 year (365 days) of diagnosis for women under the age of 70 receiving breast conservation surgery for breast cancer (Accountability).
Colorectal
ADJUVANT CHEMOTHERAPY (ACT)
Adjuvant chemotherapy is recommended, or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer (Accountability).
12 REGIONAL LYMPH NODES (12RLN)
At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer (Quality Improvement).
LUNG
LUNG CHEMOTHERAPY (LCT)
Systemic chemotherapy is administered within 4 months to the day of surgery preoperatively or day of surgery to 6 months postoperatively, or it is recommended for surgically resected cases with pathologic lymph nodepositive (pN1) and (pN2) NSCLC (Quality Improvement).
Maury regional cancer center 2017 performance
While comparative data across CoC cancer centers is only available through 2016, below is 2017 data for Maury Regional Cancer Center compared to CoC national standards.
KEY:
MRCC - Maury Regional Cancer Center
CCCP - Commission on Cancer Comprehensive Community Cancer Program (programs treating more than 800 patients)
TN - Commission on Cancer Programs in Tennessee
All CoC - Commission on Cancer Programs Nationwide
Red Line - Commission on Cancer Standard